Document is current
Any future updates will be listed below
-
Authors
Credle, Joel J.
Gunn, Jonathan
Sangkhapreecha, Puwanat
Monaco, Daniel R.
Zheng, Xuwen Alice
Tsai, Hung-Ji
Wilbon, Azaan
Morgenlander, William R.
Rastegar, Andre
Dong, Yi
Jayaraman, Sahana
Tosi, Lorenzo
Parekkadan, Biju
Baer, Alan N.
Roederer, Mario
Bloch, Evan M.
Tobian, Aaron A. R.
Zyskind, Israel
Silverberg, Jonathan I.
Rosenberg, Avi Z.
Cox, Andrea L.
Lloyd, Tom
Mammen, Andrew L.
Benjamin Larman, H. https://orcid.org/0000-0001-7863-196X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01GM127353)
- License Information
-
More Information
Article History
Received: 7 May 2021
Accepted: 14 July 2022
First Online: 19 August 2022
Competing interests
: H.B.L., J.J.C., J.G. and P.S. are listed as inventors on a patent application filed by Johns Hopkins University that covers the MIPSA technology. H.B.L. is a founder of Portal Bioscience, Alchemab and ImmuneID, and an advisor to TScan Therapeutics. The other authors declare no competing interests.
Free to read: This content has been made available to all.
